Everolimus with optimized cyclosporine dosing in renal transplant recipients: 6-month safety and efficacy results of two randomized studies.
Vitko S, Tedesco H, Eris J, Pascual J, Whelchel J, Magee JC, Campbell S, Civati G, Bourbigot B, Alves Filho G, Leone J, Garcia VD, Rigotti P, Esmeraldo R, Cambi V, Haas T, Jappe A, Bernhardt P, Geissler J, Cretin N.
Vitko S, et al. Among authors: pascual j.
Am J Transplant. 2004 Apr;4(4):626-35. doi: 10.1111/j.1600-6143.2004.00389.x.
Am J Transplant. 2004.
PMID: 15023156
Free article.
Clinical Trial.